Biomarker Discovery: Known Terrain or Uncharted Territory?
March 26-27, 2013
The Royal Palms Resort and Spa
The goal of the second NBDA workshop was to carefully consider the earliest and one of the most important modules of biomarker development. The difficult questions were associated with “first level” discovery—translatable discovery—and early assay development. These are areas where standards are no doubt critical, yet we have not succeeded in addressing the standards needed for decision-making. The think tank focused on clinical questions related to bio-specimens, technologies, and NBDA Standards* development, data development management, analysis and analytics. The group also considered the level of evidence needed to designate a biochemical change(s) or other parameter as a biomarker. We focused on demonstration projects for these early development modules.
*NBDA Standards includes but is not limited to: “official existing standards”, guidelines, principals, standard operating procedures (SOP), and best practices.
This information will be available in Spring 2016 to those individuals and organizations that join the NBDA as Partners, Collaborators or Members.